Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
May 11
German (DAX) Healthcare Sector Analysis
UpdatedMay 19, 2024
DataAggregated Company Financials
Companies62
- 7D1.6%
- 3M-1.8%
- 1Y-13.7%
- YTD-1.0%
Over the last 7 days, the Healthcare industry has risen 1.6%, driven by gains from Merck KGaA of 7.5%. In the same time, SCHOTT Pharma KGaA was down 14%. In contrast, the industry has lost 14% in the last 12 months. As for the next few years, earnings are expected to grow by 20% per annum.
Sector Valuation and Performance
Has the German Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 19 May 2024 | €238.2b | €158.6b | €3.5b | 26.3x | 67.9x | 1.5x |
| Tue, 16 Apr 2024 | €233.7b | €159.1b | €3.4b | 24.4x | 68.9x | 1.5x |
| Thu, 14 Mar 2024 | €243.3b | €178.4b | €4.0b | 21.6x | 60.7x | 1.4x |
| Sat, 10 Feb 2024 | €237.2b | €179.1b | €3.4b | 22.5x | 68.8x | 1.3x |
| Mon, 08 Jan 2024 | €241.7b | €188.4b | €3.3b | 21.3x | 73.6x | 1.3x |
| Wed, 06 Dec 2023 | €243.6b | €188.4b | €3.3b | 22.9x | 74.1x | 1.3x |
| Fri, 03 Nov 2023 | €234.4b | €189.2b | €8.6b | 20.8x | 27.3x | 1.2x |
| Sun, 01 Oct 2023 | €256.4b | €189.6b | €8.8b | 22x | 29.3x | 1.4x |
| Tue, 29 Aug 2023 | €261.0b | €189.4b | €8.8b | 23.5x | 29.6x | 1.4x |
| Thu, 27 Jul 2023 | €269.7b | €190.9b | €10.5b | 23.8x | 25.8x | 1.4x |
| Sat, 24 Jun 2023 | €260.1b | €191.0b | €10.5b | 23.7x | 24.7x | 1.4x |
| Mon, 22 May 2023 | €276.2b | €190.9b | €10.4b | 24x | 26.4x | 1.4x |
| Wed, 19 Apr 2023 | €282.3b | €190.7b | €12.6b | 22.5x | 22.4x | 1.5x |
| Fri, 17 Mar 2023 | €273.0b | €190.6b | €12.8b | 18.3x | 21.3x | 1.4x |
| Sun, 12 Feb 2023 | €290.9b | €187.7b | €13.8b | 18.3x | 21.1x | 1.5x |
| Tue, 10 Jan 2023 | €278.9b | €187.6b | €13.9b | 18.4x | 20.1x | 1.5x |
| Thu, 08 Dec 2022 | €269.4b | €187.4b | €13.8b | 20.3x | 19.5x | 1.4x |
| Sat, 05 Nov 2022 | €256.9b | €183.1b | €13.4b | 18.9x | 19.2x | 1.4x |
| Mon, 03 Oct 2022 | €246.8b | €182.3b | €13.4b | 17.8x | 18.5x | 1.4x |
| Wed, 31 Aug 2022 | €270.5b | €182.3b | €13.4b | 21.3x | 20.2x | 1.5x |
| Fri, 29 Jul 2022 | €288.5b | €178.6b | €11.4b | 24.7x | 25.4x | 1.6x |
| Sun, 26 Jun 2022 | €273.9b | €178.4b | €11.3b | 23.3x | 24.2x | 1.5x |
| Tue, 24 May 2022 | €301.1b | €185.8b | €11.3b | 21.8x | 26.5x | 1.6x |
| Thu, 21 Apr 2022 | €315.0b | €179.9b | €10.1b | 25.9x | 31.3x | 1.8x |
| Sat, 19 Mar 2022 | €312.6b | €179.4b | €10.1b | 23x | 31.1x | 1.7x |
| Mon, 14 Feb 2022 | €308.6b | €176.6b | €9.3b | 26.8x | 33.2x | 1.7x |
| Wed, 12 Jan 2022 | €332.7b | €175.4b | €9.3b | 27x | 35.9x | 1.9x |
| Fri, 10 Dec 2021 | €348.2b | €158.6b | €9.3b | 29.2x | 37.6x | 2.2x |
| Sun, 07 Nov 2021 | €340.6b | €155.0b | €1.2b | 29x | 296.1x | 2.2x |
| Tue, 05 Oct 2021 | €321.1b | €154.3b | €1.3b | 28.4x | 249.4x | 2.1x |
| Thu, 02 Sep 2021 | €353.7b | €171.3b | €1.3b | 30.9x | 282.7x | 2.1x |
| Sat, 31 Jul 2021 | €324.3b | €171.3b | €1.3b | 29.4x | 259.1x | 1.9x |
Price to Earnings Ratio
-41.5x
Current Industry PE
- Investors are optimistic on the German Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 67.9x which is higher than its 3-year average PE of 59.4x.
- The industry is trading close to its 3-year average PS ratio of 1.6x.
Past Earnings Growth
- Total earnings for the Healthcare industry have gone up over the last three years, and the industry is now profitable.
- Revenues have remained mostly flat. This means that the industry has become more efficient since profits are increasing while sales have been flat.
Industry Trends
Which industries have driven the changes within the German Healthcare sector?
| DE Market | -0.43% | |
| Healthcare | 1.61% | |
| Pharma | 4.92% | |
| Healthtech | 2.99% | |
| Medical Equipment | 0.84% | |
| Biotech | 0.63% | |
| Healthcare Services | -1.13% | |
| Life Sciences | -5.02% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 52.1x.
- Analysts are expecting annual earnings growth of 27.0%, which is higher than its past year's earnings growth of 20.2% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 34% over the next 5 years.
- This is better than its past earnings decline of 28% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 43% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MRK Merck KGaA | €167.20 | 7.5% +€5.1b | 0.5% | PE26.7x | |
| SHL Siemens Healthineers | €52.88 | 0.6% +€334.7m | -1.7% | PE32.1x | |
| DMP Dermapharm Holding | €37.40 | 6.9% +€129.2m | -18.1% | PE35.6x | |
| EUZ Eckert & Ziegler | €46.50 | 14.3% +€121.2m | -3.8% | PE28.6x | |
| MOR MorphoSys | €69.35 | 3.5% +€88.5m | 203.4% | PS10.8x |
